MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell

Molecular and Cellular Biochemistry

Volumn 387, Issue 1-2, 2014, Pages 71-79

  Kim, Jae Sung ^a   Park, Sun Young ^a   Lee, Seul Ah ^a   Park, Min Gyeong ^a   Yu, Sun Kyoung ^a   Lee, Myoung Hwa ^a   Park, Mi Ra ^a   Kim, Su Gwan ^a   Oh, Ji Su ^a   Lee, Sook Young ^a   Kim, Chun Sung ^a   Kim, Heung Joong ^a   Chun, Hong Sung ^a   Kim, Jin Soo ^a   Moon, Sung Min ^a   Kim, Do Kyung ^a  

^a Chosun University   (South Korea)

Author keywords

Apoptosis; AXIN 2; MicroRNA (miRNA); Oncogenic activity; Oral carcinoma

Indexed keywords

3' UNTRANSLATED REGIONS; APOPTOSIS; AXIN PROTEIN; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOUTH NEOPLASMS; RNA INTERFERENCE;

EID: 84893867971     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1872-7     Document Type: Article

References (26)

1. Cho HJ, Liu G, Jin SM, Parisiadou L, Xie C, Yu J, Sun L, Ma B, Ding J, Vancraenenbroeck R, Lobbestael E, Baekelandt V, Taymans JM, He P, Troncoso JC, Shen Y, Cai H (2013) MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22:608-620. doi: 10.1093/hmg/dds470
2. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS (2011) A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA 108:9863-9868. doi: 10.1073/pnas.1018493108
3. Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J (2013) Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 25:46-54. doi: 10.3978/j.issn.1000-9604.2012.11.04
4. Kim JS, Yu SK, Lee MH, Park MG, Park E, Kim SG, Lee SY, Kim CS, Kim HJ, Chun HS, Chun SW, Kim do K (2013) MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells. Mol Cells 35:17-24. doi: 10.1007/s10059-013-2154-7
5. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, Deng G, Dahiya R (2010) MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116:5637-5649. doi: 10.1002/cncr.25488
6. Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH, Muller PA, Dotsch V, Kehrloesser S, Sayan BS, Giaccone G, Lowe SW, Takahashi N, Vandenabeele P, Knight RA, Levine AJ, Melino G (2012) Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA 109:15312-15317. doi: 10.1073/pnas.1110977109
7. Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger B, Guo J, Xu X (2012) Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest 92:1084-1096. doi: 10.1038/labinvest.2012.62
8. Yue X, Wang P, Xu J, Zhu Y, Sun G, Pang Q, Tao R (2012) MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol Rep 27:1200-1206. doi: 10.3892/or.2011.1588
9. Song H, Bu G (2009) MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. Biochem Biophys Res Commun 388:400-405. doi: 10.1016/j.bbrc.2009.08.020
10. Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Menard S, Croce CM, Tagliabue E (2009) microRNA-205 regulates HER3 in human breast cancer. Cancer Res 69:2195-2200. doi: 10.1158/0008-5472.CAN-08-2920
11. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R (2011) MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res 71:2611-2621. doi: 10.1158/0008-5472.CAN-10-3666
12. Verdoodt B, Neid M, Vogt M, Kuhn V, Liffers ST, Palisaar RJ, Noldus J, Tannapfel A, Mirmohammadsadegh A (2013) MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. Int J Oncol 43:307-314. doi: 10.3892/ijo.2013.1915
13. Noguchi S, Iwasaki J, Kumazaki M, Mori T, Maruo K, Sakai H, Yamada N, Shimada K, Naoe T, Kitade Y, Akao Y (2013) Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. Mol Ther. doi: 10.1038/mt.2013.70
14. Gandellini P, Profumo V, Casamichele A, Fenderico N, Borrelli S, Petrovich G, Santilli G, Callari M, Colecchia M, Pozzi S, De Cesare M, Folini M, Valdagni R, Mantovani R, Zaffaroni N (2012) miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ 19:1750-1760. doi: 10.1038/cdd.2012.56
15. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172-1183 (Pubitemid 34094853)
16. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22:1184-1193 (Pubitemid 34094854)
17. Cheng CW, Smith SK, Charnock-Jones DS (2003) Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology. Exp Cell Res 291:415-425 (Pubitemid 37485729)
18. Masckauchan TN, Shawber CJ, Funahashi Y, Li CM, Kitajewski J (2005) Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 8:43-51. doi: 10.1007/s10456-005-5612-9 (Pubitemid 41223838)
19. Ille F, Atanasoski S, Falk S, Ittner LM, Marki D, Buchmann-Moller S, Wurdak H, Suter U, Taketo MM, Sommer L (2007) Wnt/BMP signal integration regulates the balance between proliferation and differentiation of neuroepithelial cells in the dorsal spinal cord. Dev Biol 304:394-408. doi: 10.1016/j.ydbio.2006.12.045 (Pubitemid 46399692)
20. Espada J, Calvo MB, Diaz-Prado S, Medina V (2009) Wnt signalling and cancer stem cells. Clin Transl Oncol 11:411-427
21. Gaujoux S, Hantel C, Launay P, Bonnet S, Perlemoine K, Lefevre L, Guillaud-Bataille M, Beuschlein F, Tissier F, Bertherat J, Rizk-Rabin M, Ragazzon B (2013) Silencing mutated beta-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R. PLoS One 8:e55743. doi: 10.1371/journal.pone.0055743
22. Behrens J (2005) The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans 33:672-675. doi: 10.1042/BST0330672 (Pubitemid 41160836)
23. Pan KF, Liu WG, Zhang L, You WC, Lu YY (2008) Mutations in components of the Wnt signaling pathway in gastric cancer. World J Gastroenterol 14:1570-1574 (Pubitemid 351460174)
24. Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH (2009) Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum Pathol 40:58-64. doi: 10.1016/j.humpath.2008.06.006
25. Kim NH, Cha YH, Kang SE, Lee Y, Lee I, Cha SY, Ryu JK, Na JM, Park C, Yoon HG, Park GJ, Yook JI, Kim HS (2013) p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. Cell Cycle 12:1578-1587. doi: 10.4161/cc.24739
26. Wu ZQ, Brabletz T, Fearon E, Willis AL, Hu CY, Li XY, Weiss SJ (2012) Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity. Proc Natl Acad Sci USA 109:11312-11317. doi: 10.1073/pnas.1203015109